Elin Heldbo Reines

Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Ulla Lepola, Henrik Loft, Elin Heldbo Reines · International Clinical Psychopharmacology · 2003 · 225 citations

Psychotropic Medication, Psychopharmacology, Mg/day Citalopram +19

Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Ulla Lepola, Henrik Loft, Elin Heldbo Reines · International Clinical Psychopharmacology · 2003 · 183 citations

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

David S. Baldwin, Lambros Chrones, Ioana Florea et al. · Journal of Psychopharmacology · 2016 · 182 citations · Full text

Escitalopram (S-Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat Model

Stuart Montgomery, Henrik Loft, Connie Sánchez et al. · Pharmacology & Toxicology · 2001 · 154 citations

Psychotropic Medication, Psychopharmacology, Mg/day Citalopram +21

A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

Lucien Colonna, Henning Friis Andersen, Elin Heldbo Reines · Current Medical Research and Opinion · 2005 · 84 citations